Eric Dobmeier - Insider Trading & Ownership

Location
C/O Saettle Genetics Inc, 21823 30 Th Drive Se, Bothell, WA
Summary
The estimated net worth of Eric Dobmeier is at least $474K dollars as of June 25, 2025. Eric Dobmeier is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $255K. Eric Dobmeier is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $219K.
Signature
/s/ Jun Yoon, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Eric Dobmeier

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
JANX Janux Therapeutics, Inc. Director $255K Jun 11, 2025
ATRA Atara Biotherapeutics, Inc. Director $219K Nov 10, 2023
JBIO Jade Biosciences, Inc. Director Apr 29, 2025
KDNY CHINOOK THERAPEUTICS, INC. President, CEO, Director Aug 11, 2023
GPCR Structure Therapeutics Inc. Director Jun 23, 2025

Insider Transactions Reported by Eric Dobmeier:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.